NC-2800 / Nippon Chemiphar, Sumitomo Pharma - LARVOL DELTA

Chemiphar and Sumitomo Dainippon partner on novel CNS candidate NC-2800 (The Pharma Letter) - "Shares of Nippon Chemiphar (TYO: 4539) shot up 22% to 2,771 yen today, after it disclosed a partnership with fellow Japanese drugmaker Sumitomo Dainippon Pharma (TYO: 4506). Chemiphar and Sumitomo Dainippon have concluded a collaborative research and development agreement and an option agreement for a novel antidepressant/anxiolytic candidate compound - NC-2800 – which is currently at non-clinical stage, that is under research and development by Chemiphar."

Licensing / partnership • Stock price • CNS Disorders • Depression

Research and development of κ opioid receptor agonists and δ opioid receptor agonists. (PubMed, Pharmacol Ther) - "Very recently, we developed another delta agonist NC-2800 with a different structure. NC-2800 is now in the preclinical stage using the CiCLE fund supported by AMED (Japanese Agency for Medical Research and Development)."

Journal